Everest Medicines gibt Termin für außerordentliche Hauptversammlung bekannt
I'm PortAI, I can summarize articles.
Everest Medicines Ltd. will hold an extraordinary general meeting on February 22, 2026, as a virtual session. The agenda includes the approval of ongoing connected transactions related to the Commercialization Service Agreement, proposed allocation of shares to a connected person, application for a waiver of certain requirements, and the planned introduction of the 2026 Share Scheme. This information was published via the Issuer Information Service by the Hong Kong Stock Exchange.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments